Metabolic changes reveal the development of schistosomiasis in mice

PLoS Neglected Tropical Diseases

Volumn 4, Issue 8, 2010, Pages

  Wu, Junfang ^a,b   Xu, Wenxin ^a,b   Ming, Zhenping ^c   Dong, Huifen ^c   Tang, Huiru ^a   Wang, Yulan ^a  

^a Wuhan National Laboratory for Optoelectronics   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 UREIDOPROPIONATE; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CITRIC ACID CYCLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; GLYCOLYSIS; HOST PARASITE INTERACTION; INTESTINE FLORA; LIPID METABOLISM; METABOLISM; METABONOMIC ANALYSIS; MOUSE; NONHUMAN; SCHISTOSOMA; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; TISSUE METABOLISM; TISSUE SECTION; URINALYSIS;

ANIMALS; BODY FLUIDS; CITRIC ACID CYCLE; FEMALE; GLYCOLYSIS; LIPID METABOLISM; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED BALB C; SCHISTOSOMA; SCHISTOSOMIASIS; UREA;

EID: 78149232698     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000807     Document Type: Article

References (57)

1. Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, et al. (2002) Schistosomiasis. N Engl J Med 346: 1212-1220.
2. Wang LD, Utzinger J, Zhou XN (2008) Schistosomiasis control: experiences and lessons from China. The Lancet 372: 1793-1795.
3. Zhao GM, Zhao Q, Jiang QW, Chen XY, Wang LY, et al. (2005) Surveillance for schistosomiasis japonica in China from 2000 to 2003. Acta Trop 96: 288-295.
4. Utzinger J, Booth M, N'Goran EK, Muller I, Tanner M, et al. (2001) Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitology 122: 537-544.
5. Noya O, Losada S, Alarcon de Noya B, Gonzalez S, Hermoso T, et al. (1995) Effect of chemotherapy on immune response to egg antigens of Schistosoma mansoni in chronically infected children from areas of low transmission. Parasite Immunol 17: 111-117.
6. De Noya BA, Spencer L, Noya O (1992) Pre- and post-treatment immunodiagnostic evaluation in human Schistosomiasis mansoni. Mem Inst Oswaldo Cruz 87 Suppl 4: 271-276.
7. Zern MA, Saber MA, Shafritz DA (1983) Molecular mechanisms for changes in hepatic protein synthesis induced by schistosomiasis infection in mice. Biochemistry 22: 6072-6077.
8. Harvie M, Jordan TW, La Flamme AC (2007) Differential liver protein expression during schistosomiasis. Infect Immun 75: 736-744.
9. Liu F, Hu W, Cui SJ, Chi M, Fang CY, et al. (2007) Insight into the host-parasite interplay by proteomic study of host proteins copurified with the human parasite, Schistosoma japonicum. Proteomics 7: 450-462.
10. Ahmed SA, Gad MZ (1995) Effect of schistosomal infection and its treatment on some key enzymes of glucose metabolism in mice livers. Arzneimittelforschung 45: 1324-1328.
11. Tanabe M, Kaneko N, Takeuchi T (1989) Schistosoma mansoni: suppression of carbamoyl phosphate synthetase (ammonia) and ornithine carbamoyltransferase activities in the liver of infected mice. Exp Parasitol 68: 432-442.
12. Tang HR, Wang YL (2006) Metabonomics: a revolution in progress. Prog Biochem Biophys 33: 401-417.
13. van Ravenzwaay B, Cunha GC, Leibold E, Looser R, Mellert W, et al. (2007) The use of metabolomics for the discovery of new biomarkers of effect. Toxicol Lett 172: 21-28.
14. Nicholson JK, Lindon JC, Holmes E (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29: 1181-1189.
15. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, et al. (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 8: 1439-1444.
16. Yang Y, Li C, Nie X, Feng X, Chen W, et al. (2007) Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis. J Proteome Res 6: 2605-2614.
17. Zhang XY, Wang YL, Hao FH, Zhou XH, Han XY, et al. (2009) Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses. J Proteome Res 8: 5188-5195.
18. Waters NJ, Waterfield CJ, Farrant RD, Holmes E, Nicholson JK (2005) Metabonomic deconvolution of embedded toxicity: application to thioacetamide hepato- and nephrotoxicity. Chem Res Toxicol 18: 639-654.
19. Yap IK, Clayton TA, Tang HR, Everett JR, Hanton G, et al. (2006) An integrated metabonomic approach to describe temporal metabolic disregulation induced in the rat by the model hepatotoxin allyl formate. J Proteome Res 5: 2675-2684.
20. Bundy JG, Lenz EM, Bailey NJ, Gavaghan CL, Svendsen C, et al. (2002) Metabonomic assessment of toxicity of 4-fluoroaniline, 3,5-difluoroaniline and 2- fluoro-4-methylaniline to the earthworm Eisenia veneta (Rosa): identification of new endogenous biomarkers. Environ Toxicol Chem 21: 1966-1972.
21. Ding LN, Hao FH, Shi ZM, Wang YL, Zhang HX, et al. (2009) Systems biological responses to chronic perfluorododecanoic acid exposure by integrated metabonomic and transcriptomic studies. J Proteome Res 8: 2882-2891.
22. Holmes E, Tang H, Wang Y, Seger C (2006) The assessment of plant metabolite profiles by NMR-based methodologies. Planta Med 72: 771-785.
23. Rezzi S, Ramadan Z, Martin FP, Fay LB, van Bladeren P, et al. (2007) Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals. J Proteome Res 6: 4469-4477.
24. Wang YL, Utzinger J, Saric J, Li JV, Burckhardt J, et al. (2008) Global metabolic responses of mice to Trypanosoma brucei brucei infection. Proc Natl Acad Sci U S A 105: 6127-6132.
25. Li JV, Wang YL, Saric J, Nicholson JK, Dirnhofer S, et al. (2008) Global metabolic responses of NMRI mice to an experimental Plasmodium berghei infection. J Proteome Res 7: 3948-3956.
26. Saric J, Li JV, Wang YL, Keiser J, Bundy JG, et al. (2008) Metabolic profiling of an Echinostoma caproni infection in the mouse for biomarker discovery. PLoS Negl Trop Dis 2: e254.
27. Saric J, Li JV, Wang YL, Keiser J, Veselkov K, et al. (2009) Panorganismal metabolic response modeling of an experimental Echinostoma caproni infection in the mouse. J Proteome Res 8: 3899-3911.
28. Wang YL, Holmes E, Nicholson JK, Cloarec O, Chollet J, et al. (2004) Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc Natl Acad Sci U S A 101: 12676-12681.
29. Wang YL, Utzinger J, Xiao SH, Xue J, Nicholson JK, et al. (2006) System level metabolic effects of a Schistosoma japonicum infection in the Syrian hamster. Mol Biochem Parasitol 146: 1-9.
30. Li JV, Holmes E, Saric J, Keiser J, Dirnhofer S, et al. (2009) Metabolic profiling of a Schistosoma mansoni infection in mouse tissues using magic angle spinningnuclear magnetic resonance spectroscopy. Int J Parasitol 39: 547-558.
31. Wu JF, Holmes E, Xue J, Xiao SH, Singer BH, et al. (2010) Metabolic alterations in the hamster co-infected with Schistosoma japonicum and Necator americanus. Int J Parasitol 40: 695-703.
32. Xiao CN, Hao FH, Qin XR, Wang YL, Tang HR (2009) An optimized buffer system for NMR-based urinary metabonomics with effective pH control, chemical shift consistency and dilution minimization. Analyst 134: 916-925.
33. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E (2005) NMRbased metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed 18: 143-162.
34. Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC (1995) 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem 67: 793-811.
35. Trygg J, Wold S (2002) Orthogonal projections to latent structures (O-PLS). J Chemom 16: 119-128.
36. Trygg J (2002) O2-PLS for qualitative and quantitative analysis in multivariate calibration. J Chemom 16: 283-293.
37. Vandenberg RA, Hoefsloot H CJ, Westerhuis JA, Smilde AK, M V (2006) Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 7: 142-156.
38. Trygg J, Holmes E, Lundstedt T (2007) Chemometrics in metabonomics. J Proteome Res 6: 469-479.
39. Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, et al. (2006) Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440: 1073-1077.
40. Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, et al. (2007) Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem 79: 6995-7004.
41. Cloarec O, Dumas ME, Trygg J, Craig A, Barton RH, et al. (2005) Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. Anal Chem 77: 517-526.
42. Duarte IF, Stanley EG, Holmes E, Lindon JC, Gil AM, et al. (2005) Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Anal Chem 77: 5570-5578.
43. Tang HR, Wang YL, Nicholson JK, Lindon JC (2004) Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma. Anal Biochem 325: 260-272.
44. He YX, Yang HZ (1980) Physiological studies on the post-cercarial development of Schistosoma japonicum. Acta Zoologica Sinica 26: 32-41.
45. Doenhoff MJ, Chiodini PL, Hamilton JV (2004) Specific and sensitive diagnosis of schistosome infection: can it be done with antibodies? Trends Parasitol 20: 35-39.
46. Abdel-Rahim IM, Kaiser C, Homeida M, Elsheikh M, Schmidt E, et al. (1990) Enzyme activities and protein concentrations in serum of patients with hepatosplenic schistosomiasis. Trop Med Parasitol 41: 262-264.
47. Cho SG, Kim MY, Kim HJ, Kim YS, Choi W, et al. (2001) Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 221: 740-746.
48. Shioda R, Reinach PS, Hisatsune T, Miyamoto Y (2002) Osmosensitive taurine transporter expression and activity in human corneal epithelial cells. Invest Ophthalmol Vis Sci 43: 2916-2922.
49. Saule P, Vicogne J, Delacre M, Macia L, Tailleux A, et al. (2005) Host glucose metabolism mediates T4 and IL-7 action on Schistosoma mansoni development. J Parasitol 91: 737-744.
50. Allan D, Payares G, Evans WH (1987) The phospholipid and fatty acid composition of Schistosoma mansoni and of its purified tegumental membranes. Mol Biochem Parasitol 23: 123-128.
51. Brouwers JF, Skelly PJ, Van Golde LM, Tielens AG (1999) Studies on phospholipid turnover argue against sloughing of tegumental membranes in adult Schistosoma mansoni. Parasitology 119: 287-294.
52. Baumheuer ME, Zerfass M, Ruppel A, Leichsenring M (1994) The fatty acid composition of plasma and erythrocytes in Schistosoma mansoni-infected mice. Trop Med Parasitol 45: 5-8.
53. Mousa W, Kheir-Eldin AA, Elsehly A, Mousa AH (1975) Lipid pattern in Bilharzial hepatic fiprosis. Egypt J Bilharz 2: 83-93.
54. Wang YL, Xiao SH, Xue J, Singer BH, Utzinger J, et al. (2009) Systems metabolic effects of a Necator americanus infection in Syrian hamster. J Proteome Res 8: 5442-5450.
55. Garcia-Perez I, Couto Alves A, Angulo S, Li JV, Utzinger J, et al. (2010) Bidirectional correlation of NMR and capillary electrophoresis fingerprints: a new approach to investigating Schistosoma mansoni infection in a mouse model. Anal Chem 82: 203-210.
56. Moolenaar SH, Gohlich-Ratmann G, Engelke UF, Spraul M, Humpfer E, et al. (2001) beta-Ureidopropionase deficiency: a novel inborn error of metabolism discovered using NMR spectroscopy on urine. Magn Reson Med 46: 1014-1017.
57. Kolker S, Okun JG, Horster F, Assmann B, Ahlemeyer B, et al. (2001) 3- Ureidopropionate contributes to the neuropathology of 3-ureidopropionase deficiency and severe propionic aciduria: a hypothesis. J Neurosci Res 66: 666-673.